Use of immunohistochemical marker calretinin in the diagnosis of a diffuse malignant metastatic mesothelioma in an equine.

The research article is about a case study of a rare occurrence of metastatic mesothelioma in a 6-year-old horse, diagnosed using the immunohistochemical marker calretinin for the first time in an equine species.

Detailed Overview of the Research

• The research focuses on a case study involving an Arabian mare of six years old diagnosed with a generalized, biphasic mesothelioma, a rare form of cancer in animal species. The mare presented ascites, pleural effusion, and pleural roughening during the clinical examination.
• Upon necropsy, the researchers observed an accumulation of fluid in the abdominal and thoracic cavities. The animal’s organ surfaces were abnormally thick and fibrosed, exhibiting several raised nodules and hemorrhages.
• The histological analysis indicated the presence of a generalized mesothelioma with noticeable vascular and lymph nodes metastases. The research team hypothesizes that the primary cancerous growth had its origin in the pericardium and later spread through the lymphatic pathways.
• Noteworthy in this study was the employment of calretinin as an immunohistochemical marker for the diagnostic procedure. Calretinin, a usually human-associated marker, has been used in this context with an equine species for the first time. Immunohistochemical markers, such as calretinin, are crucial in the diagnostic process as they assist in identifying the cell where the cancer originated.

Significance of the Findings

• The use of Calretinin as an immunohistochemical marker in diagnosing mesothelioma in horses, as reported in this study, underscores the potential for cross-species application of diagnostic markers.
• This application of calretinin has broadened the scope for improved diagnostic procedures in equine species. As it is, this case study brings new insights into understanding and diagnosing mesothelioma in animals, potentially leading to more effective therapeutic strategies.
• The identified characteristics of the presented mesothelioma could also contribute to the general understanding of this rare cancer, possibly benefiting both veterinary and human medicine.